SWOG S1815 Shows Need for Subgroup-Specific Triplet Chemotherapy Assessment in Biliary Tract Cancer
Understanding the Role of Triplet Chemotherapy in Advanced Biliary Tract Cancers Triplet chemotherapy regimens, such as the combination of nab-paclitaxel, gemcitabine, and cisplatin (GAP), have shown modest improvements in certain subgroups of patients with advanced biliary tract cancers. However, the phase 3 SWOG S1815 trial did not demonstrate a significant overall benefit in overall survival … Read more